A*STAR researchers have homed in on a potential new way to diagnose and treat stomach cancer, through the mapping of an unprecedented catalog of almost 3,800 super-enhancers from stomach cancer tumor cells.
Jul 26, 2017
0
26
More precise estimates of age-associated risks of gastric and breast cancer were derived for carriers of the CDH1 gene mutation, a cancer predisposing gene that is abnormal in families meeting criteria for clinically defined ...
Feb 12, 2015
0
20
Patient and structural factors contribute to significant geographic differences in mortality from gastrointestinal (GI) cancers, according to a study published in the August issue of Gastroenterology.
Jul 26, 2022
0
19
Gastric cancer is the fourth leading cause of cancer-related mortalities worldwide. Various environmental and lifestyle-related factors, like tobacco and alcohol consumption, are known to contribute to the risk of gastric ...
Oct 26, 2023
0
16
Gastric cancer is one of the most common malignant cancers worldwide. Since the stage of early gastric cancer usually lasts for a long time and lacks obvious symptoms, the diagnosis of early gastric cancer is very difficult. ...
Jan 22, 2021
0
4
Whole-genome sequencing gives researchers a deeper understanding of factors contributing to the onset and progression of gastric cancer.
Jul 17, 2013
0
0
The immunochemical fecal occult blood test (iFOBT) is effective for predicting lesions in the lower intestine but not in the upper gastrointestinal (GI) tract, confirms a study in CMAJ (Canadian Medical Association Journal).
Aug 2, 2011
0
1
Cardiff University researchers have uncovered new information about the underlying mechanisms for gastric cancer, providing hope of potential new therapies in the future.
Jan 29, 2019
0
3
(HealthDay)—Racial and ethnic disparities in the use of preoperative chemotherapy exist among patients with gastric cancer in the United States, according to a study published online Feb. 2 in Cancer.
Feb 13, 2018
0
4
A tumor is not a uniform mass of identical cells. However, teasing apart genetic heterogeneity within a biopsied tumor can be difficult. Researchers often fail to tell the difference between a rare variant in a DNA dataset ...
Apr 24, 2013
0
0
